France at odds with European medicines agency over Pill

France insisted Friday on restricting the prescription of newer-generation birth control pills even as Europe's medicines watchdog declared there was no evidence to merit a health warning.

Citing concerns over risks of from the so-called 3rd- and 4th-generation pills, France said it would limit prescriptions of these contraceptives and urged the European Union (EU) to follow suit.

French Marisol Touraine urged the EU to consider a restriction on prescribing the contraceptives and announced a French "directive" to achieve the same.

"We will ask Europe not to suspend but to modify" the prescription guidelines for the pills, said Dominique Maraninchi of the French medicines watchdog, who spoke alongside Touraine at a press conference.

The European Medicines Agency (EMA) earlier said there was no basis for changing guidelines.

"There is currently no new evidence that would suggest any change to the known safety profile of any combined contraceptives marketed today," the agency said in a statement from London.

"Therefore, there is no reason for any woman to stop using her contraception."

add to favorites email to friend print save as pdf

Related Stories

US reviews birth control pill safety over clot risk

May 31, 2011

The US Food and Drug Administration said Tuesday it is reviewing recently published studies which have pointed to an increased blood clot risk associated with a certain type of birth control pill.

Recommended for you

Health care M&A leads global deal surge

44 minutes ago

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.